Chronic cutaneous lupus erythematosus

4 trials 1 recruiting MedDRA PT
4 Registered trials
1 Recruiting
2 Unique sponsors
2 Unique IMPs
4 Commercial trials
Drug classes (ATC)
— ATC code not specified 4
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune) 1 substance
Unknown / small molecule 1 substance
Phase III: 3 Phase II/III: 1

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase III

3 trials
  • Biogen Idec Research Limited Commercial
    LITIFILIMAB
    2023-504863-17-00 11 countries 2024 n=202
    Recruiting
  • Merck Healthcare KGaA Commercial
    ENPATORAN HEMIHYDRATE
    2025-523871-44-00 10 countries n=54
    Pending
  • Merck Healthcare KGaA Commercial
    ENPATORAN HEMIHYDRATE
    2025-524855-30-00 10 countries n=57
    Pending

Phase II/III

1 trial
  • Biogen Idec Research Limited Commercial
    LITIFILIMAB
    2023-505634-94-00 11 countries 2023 n=217
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Biogen Idec Research Limited Commercial 2 Phase II/III, Phase III 1
Merck Healthcare KGaA Commercial 2 Phase III 0
New trials by year
2023
1
2024
1
← All indication landscapes